Speak directly to the analyst to clarify any post sales queries you may have.
Primaquine phosphate tablets play a critical role in global malaria control strategies, underpinning radical cure protocols that address both relapse prevention and public health objectives. Senior stakeholders in healthcare, pharmaceuticals, and procurement will find that this market continues to evolve in response to shifting guidelines and operational requirements.
Market Snapshot
The primaquine phosphate tablets market is experiencing dynamic growth, driven by rising adoption within national malaria eradication campaigns and the expansion of dosing options for adults and children. Market momentum is continually influenced by evolving treatment protocols, advances in manufacturing technology, and shifts in global supply chains. Key trends include diversification by strength and packaging format to address varied programmatic and clinical demands, as well as broadening access via public and private distribution channels.
Scope & Segmentation
- Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy environments are central to market reach, each responding to specific patient and procurement needs.
- Strengths: Multiple dosage forms, including 15 mg, 26.3 mg, and 7.5 mg, enable dosing flexibility across patient populations.
- Patient Age: Distinct product development for adult and pediatric groups—pediatric-friendly options prioritize ease of administration and safety profiles.
- Treatment Regimens: Market offerings span combination therapies and monotherapies, routinely shaping joint licensing agreements and co-packaging strategies.
- Packaging Types: Blister packs enhance dose tracking; bottles support volume distribution, particularly within scaled-up mass drug administration initiatives.
- Regional Markets: The Americas focus on large-scale distribution alliances; Europe, Middle East & Africa benefit from harmonized regulatory pathways; Asia-Pacific leads in advanced manufacturing capacity and consumption growth.
- Technologies: Incorporation of continuous manufacturing, digital quality management, and predictive analytics has established new benchmarks for operational efficiency.
Key Takeaways
- Primaquine phosphate tablets remain central in radical cure regimens, reinforcing their status in both clinical and public health programs.
- Pediatric forms have gained visibility, prompting investments in formulation science and improved packaging for younger patients.
- Collaboration between industry, NGOs, and public health agencies has accelerated effective mass drug administration and deployment in hard-to-reach regions.
- Technological innovation, including real-time monitoring and continuous production, supports batch consistency and compliance with international requirements.
- Agile responses to regulatory shifts enable timely market entry for reformulated and combination therapies.
- Outcomes-based contracting is increasingly pivotal for aligning commercial models with payer objectives and sustained access initiatives.
Tariff Impact
United States tariff policies are reshaping the global primaquine phosphate tablets market by driving changes in sourcing strategies and the relocation of manufacturing closer to target markets. New cost structures have prompted vertical integration, with firms investing in upstream supply and in-house processing to control expenses. Inventory management and closer collaboration with customs professionals have emerged as critical tools for mitigating risk and ensuring supply continuity. These industry adaptations support market stability and allow companies to better navigate regulatory documentation challenges linked to tariff regimes.
Methodology & Data Sources
This analysis integrates comprehensive secondary research—covering scientific studies, regulatory reports, and industry data—with targeted primary interviews among executives, clinical authorities, and logistics experts. Field insights were validated through quantitative and qualitative triangulation, and findings are substantiated using diverse sources from multiple regions.
Why This Report Matters
- Enables decision-makers to pinpoint areas for investment in production, compliance, and distribution networks aligned with shifting market realities.
- Supports strategic planning by delivering segment-specific insights for targeting growth in both established and emerging therapeutic segments.
- Facilitates informed responses to regulatory, operational, and supply chain challenges, particularly those stemming from international trade policies.
Conclusion
The primaquine phosphate tablets market is characterized by strategic evolution across product, regulatory, and logistical dimensions. This research equips leaders with the clarity to respond effectively to sector shifts while supporting continued public health impact and sustainable business growth.
This product will be delivered within 1-3 business days.
Table of Contents
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4.2. Market Sizing & Forecasting
5.2. Rising competition from tafenoquine head-to-head launches impacting primaquine market share dynamics in endemic regions
5.3. Impact of WHO prequalification on pricing pressures and procurement strategies for primaquine phosphate tablets
5.4. Supply chain disruptions in sub-Saharan Africa affecting availability of primaquine phosphate for malaria elimination campaigns
5.5. Integration of public private partnership models to expand access to primaquine for radical cure programs in Southeast Asia
5.6. Advances in pharmacogenomic studies guiding personalized primaquine dosing to mitigate hemolysis risk in G6PD deficient populations
5.7. Shift toward fixed-dose combination therapies incorporating primaquine for improved compliance in malaria eradication efforts
5.8. Regulatory approvals of multiple generic primaquine phosphate tablets driving increased competition and lower treatment costs in emerging markets
6.2. PESTLE Analysis
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy
9.2. 15 mg
9.3. 26.3 mg
9.4. 7.5 mg
10.2. Adult
10.3. Pediatric
11.2. Combination Therapy
11.3. Monotherapy
12.2. Blister Pack
12.3. Bottle
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Sandoz International GmbH
16.3.3. Viatris Inc.
16.3.4. Sun Pharmaceutical Industries Limited
16.3.5. Lupin Limited
16.3.6. Cipla Limited
16.3.7. Aurobindo Pharma Limited
16.3.8. Hetero Drugs Limited
16.3.9. Intas Pharmaceuticals Limited
16.3.10. Natco Pharma Limited
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
FIGURE 2. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PRIMAQUINE PHOSPHATE TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PRIMAQUINE PHOSPHATE TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PRIMAQUINE PHOSPHATE TABLETS MARKET: RESEARCHAI
FIGURE 26. PRIMAQUINE PHOSPHATE TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 27. PRIMAQUINE PHOSPHATE TABLETS MARKET: RESEARCHCONTACTS
FIGURE 28. PRIMAQUINE PHOSPHATE TABLETS MARKET: RESEARCHARTICLES
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 15 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 15 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 26.3 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 26.3 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 7.5 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 7.5 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY BLISTER PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY BLISTER PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY BOTTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY BOTTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 67. CANADA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. CANADA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. CANADA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 70. CANADA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 71. CANADA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 72. CANADA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 73. CANADA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 74. CANADA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 75. CANADA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 76. CANADA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 77. MEXICO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. MEXICO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. MEXICO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 80. MEXICO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 81. MEXICO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 82. MEXICO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 83. MEXICO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 84. MEXICO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 85. MEXICO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 86. MEXICO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED KINGDOM PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 129. GERMANY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. GERMANY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. GERMANY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 132. GERMANY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 133. GERMANY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 134. GERMANY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 135. GERMANY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 136. GERMANY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 137. GERMANY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 138. GERMANY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 139. FRANCE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. FRANCE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. FRANCE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 142. FRANCE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 143. FRANCE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 144. FRANCE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 145. FRANCE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 146. FRANCE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 147. FRANCE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 148. FRANCE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 149. RUSSIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. RUSSIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 159. ITALY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. ITALY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ITALY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 162. ITALY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 163. ITALY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 164. ITALY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 165. ITALY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 166. ITALY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 167. ITALY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 168. ITALY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 169. SPAIN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. SPAIN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. SPAIN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 172. SPAIN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 173. SPAIN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 174. SPAIN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 175. SPAIN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 176. SPAIN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 177. SPAIN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 178. SPAIN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. SAUDI ARABIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. SOUTH AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 209. DENMARK PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. DENMARK PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. DENMARK PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 212. DENMARK PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 213. DENMARK PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 214. DENMARK PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 215. DENMARK PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 216. DENMARK PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 217. DENMARK PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 218. DENMARK PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 219. NETHERLANDS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. NETHERLANDS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 229. QATAR PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. QATAR PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. QATAR PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 232. QATAR PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 233. QATAR PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 234. QATAR PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 235. QATAR PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 236. QATAR PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 237. QATAR PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 238. QATAR PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 239. FINLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. FINLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. FINLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 242. FINLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 243. FINLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 244. FINLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 245. FINLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 246. FINLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 247. FINLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 248. FINLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 249. SWEDEN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. SWEDEN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 252. SWEDEN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 259. NIGERIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. NIGERIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. NIGERIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 262. NIGERIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 269. EGYPT PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. EGYPT PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. EGYPT PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 272. EGYPT PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 273. EGYPT PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 274. EGYPT PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 275. EGYPT PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 276. EGYPT PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 277. EGYPT PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 278. EGYPT PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 279. TURKEY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. TURKEY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. TURKEY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 282. TURKEY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 283. TURKEY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 284. TURKEY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 285. TURKEY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 286. TURKEY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 287. TURKEY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 288. TURKEY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 289. ISRAEL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. ISRAEL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. ISRAEL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 292. ISRAEL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 293. ISRAEL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 294. ISRAEL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 299. NORWAY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. NORWAY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. NORWAY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 302. NORWAY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 303. NORWAY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 304. NORWAY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 305. NORWAY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 306. NORWAY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 307. NORWAY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 308. NORWAY PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 309. POLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. POLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. POLAND PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 312. POLAND PRIMAQUINE PHOSPHATE TABLETS MARKE
Samples
LOADING...
Companies Mentioned
The companies profiled in this Primaquine Phosphate Tablets market report include:- Teva Pharmaceutical Industries Ltd.
- Sandoz International GmbH
- Viatris Inc.
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Aurobindo Pharma Limited
- Hetero Drugs Limited
- Intas Pharmaceuticals Limited
- Natco Pharma Limited